Augmentin tablets

Augmentin tablets Augmentin tablets

Creative Commons LicenseThis image is released under a CC BY-NC-SA 4.0 Licence

License this image for commercial use at Science and Society Picture Library

License

Creative Commons LicenseThis image is released under a CC BY-NC-SA 4.0 Licence

License this image for commercial use at Science and Society Picture Library

License

Science Museum Group
© The Board of Trustees of the Science Museum

Science Museum Group
© The Board of Trustees of the Science Museum

Empty packaging for 7 tablets of 375 mg Augmentin (each containing 250mg amoxicillin as trihydrate and 125mg clavulanic acid as potassium salt), and instruction leaflet made by GlaxoSmithKline, United Kingdom, 2012, expiry date February 2014

Martin Cole was a microbiologist, whose career at Beecham Research Laboratories focused on the hope of developing and using semi-synthetic penicillins, including cloxacillin and amoxicillin. He led the team which first discovered and named olivanic acids and clavulanic acid and then combined the latter with amoxicillin, to produce co-amoxiclav, brand name Augmentin.

In 1957, the team at Beecham Research Laboratories discovered that penicillin grown from mould has 6-aminopenicillanic acid. By tweaking its chemical structure, scientists created medicines to treat a wider range of bacterial infections, with fewer side effects. These are known as semi-synthetic penicillins.

Details

Category:
Biotechnology
Object Number:
2025-2164
Materials:
materia medica, foil, cardboard and paper
Measurements:
overall: 36 mm x 150 mm x 74 mm,
type:
tablet